Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures

por Sanz Murillo, Marta, Villagran Suarez, Amalia, Dederer, Verena, Chatterjee, Deep, Alegrio Louro, Jaime, Knapp, Stefan, Mathea, Sebastian, Leschziner, Andres E.
Publicado 2023